| 000 | 01529 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516151219.0 | ||
| 264 | 0 | _c20130909 | |
| 008 | 201309s 0 0 eng d | ||
| 022 | _a1528-0020 | ||
| 024 | 7 |
_a10.1182/blood-2012-12-471227 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOng, Monique L | |
| 245 | 0 | 0 |
_aCpG pretreatment enhances antiviral T-cell immunity against cytomegalovirus. _h[electronic resource] |
| 260 |
_bBlood _cJul 2013 |
||
| 300 |
_a55-60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdjuvants, Immunologic _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntigen Presentation _ximmunology |
| 650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aCross-Priming _ximmunology |
| 650 | 0 | 4 |
_aCytomegalovirus _xgrowth & development |
| 650 | 0 | 4 |
_aCytomegalovirus Infections _ximmunology |
| 650 | 0 | 4 |
_aImmunocompromised Host _ximmunology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 |
_aOligodeoxyribonucleotides _xpharmacology |
| 650 | 0 | 4 |
_aSpleen _ximmunology |
| 700 | 1 | _aWikstrom, Matthew E | |
| 700 | 1 | _aFleming, Peter | |
| 700 | 1 | _aEstcourt, Marie J | |
| 700 | 1 | _aHertzog, Paul J | |
| 700 | 1 | _aHill, Geoffrey R | |
| 700 | 1 | _aAndoniou, Christopher E | |
| 700 | 1 | _aDegli-Esposti, Mariapia A | |
| 773 | 0 |
_tBlood _gvol. 122 _gno. 1 _gp. 55-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood-2012-12-471227 _zAvailable from publisher's website |
| 999 |
_c22751085 _d22751085 |
||